Files
Download Poster (723 KB)
Description
- The implementation of IDS tool, which is integrated in the Epic, can assist providers in placing appropriate BBI insulin orders.
- Increased use of BBI use can result in reduction in hyperglycemia and hypoglycemia which can enhances overall patient safety and outcomes.
- Expanding or standardizing the intervention to other areas can help change prescriber practice and better glycemic control.
- Provider involvement and interest is an important factor in the utilization of the IDS tool.
Sigi Varghese pictured.
Publication Date
2021
Recommended Citation
Varghese, Sigi APRN; Best, Conor MD; Lavis, Victor MD; Walton, Natalie C. MD; Sibille Senechalle, Michelle MD; Rizk, Michael MSN, APRN, FNP-C, BC-ADM; Ortiz, Marjorie APRN; Brady, Veronica PhD, FNP-BC, BC-ADM, CDCES; Wilson, Mara APRN; Levesque, Celia APRN; Crowder, Vivian APRN; John, Benzy APRN; Saji, Lijo DNP, APRN; Williams, Jessica PA; and Thosani, Sonali MD, "Meeting Inpatient Glycemic Targets through Increased use of Basal Bolus Insulin Therapy" (2021). APRN Week 2021. 11.
https://openworks.mdanderson.org/aprn-week-21/11
Accessibility Statement
This item was created prior to May 2026. It is preserved for research, reference, or historical recordkeeping. Following WCAG 2.1, the library may provide accessible versions of archival materials upon request. For accommodation requests please submit an accessibility request form.

